Full Press Release Details
Group Announces Launch of Bonum+ B2B Platform
Bundles Telehealth, a COVID-19 Risk Assessment Tool and a PPE Purchasing Tool, through a Secure Mobile Dashboard for Corporate
FL, August 11, 2020 - Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare
platform, today announced that its Bonum Health subsidiary has launched a first-of-its-kind Business-to-Business (B2B)
platform called Bonum+, which bundles telehealth, a COVID-19 risk assessment tool and a Personal Protective Equipment (PPE) purchasing
tool, through a secure mobile dashboard for corporate clients.
new B2B platform eases pressure on employees who are required to report any relevant health issues daily, centralizing communication
and contact tracing to deliver risk scores. This allows employers to monitor employee COVID-19 risk profiles and streamlines the
ordering of new PPE as needed. An integrated artificial intelligence (AI) tool offers health recommendations and connects employees
with board certified physicians, as needed.
am proud of the entire team at Bonum Health, a Trxade Group Company, for their efforts in launching this innovative new service,"
said Ashton Maaraba, President of Bonum Health. "This platform resolves a fundamental trust problem impacting employer's
safety and security policies, allowing companies to more effectively combat COVID-19 concerns in the workplace."
forward, we plan to continue to expand the breadth of services offered by Bonum Health, including adding a digital health hub
with next-generation prescription concierge services. We believe that we are well positioned to execute upon the immense opportunity
facing us today, supporting critical public health efforts nationwide," concluded Maaraba.
in Tampa, Florida, Trxade Group, Inc. (Nasdaq: MEDS) is an integrated drug procurement, delivery and healthcare platform
that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group
operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010,
Trxade Group is comprised of four synergistic operating platforms; (1) the Trxade B2B trading platform with 11,725 registered
pharmacies, (2) Integra Pharma Solutions, Trxade Group's virtual wholesale division, (3) the Bonum Health platform offering
affordable telehealth services; and (4) the DelivMeds app, which coordinates a nationwide distribution network through independent
pharmacies or mail order delivery. For additional information, please visit us at www.trxade.com, www.delivmeds.com,
and www.bonumhealth.com.
press release may contain forward-looking statements, including information about management's view of Trxade's future
expectations, plans and prospects, within the safe harbor provisions under The Private Securities Litigation Reform Act of 1995
(the "Act"). In particular, when used in the preceding discussion, the words "may," "could,"
"expect," "intend," "plan," "seek," "anticipate," "believe,"
"estimate," "predict," "potential," "continue," "likely," "will,"
"would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions
are intended to identify forward-looking statements within the meaning of the Act, and are subject to the safe harbor created
by the Act. Any statements made in this news release other than those of historical fact, about an action, event or development,
are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause
the results of Trxade, its divisions and concepts to be materially different than those expressed or implied in such statements.
These risk factors and others are included from time to time in filings made by Trxade with the Securities and Exchange Commission,
including, but not limited to, in the "Risk Factors" sections in its Form 10-Ks and Form 10-Qs and in its Form 8-Ks,
which it has filed, and files from time to time, with the U.S. Securities and Exchange Commission. These reports are available
at www.sec.gov. Other unknown or unpredictable factors also could have material adverse effects on Trxade's future results
and/or could cause our actual results and financial condition to differ materially from those indicated in the forward-looking
statements. The forward-looking statements included in this press release are made only as of the date hereof. Trxade cannot guarantee
future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking
statements. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new
information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except
to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that
we will make additional updates with respect to those or other forward-looking statements.
Group - MZ North America